| 前收盘价格 | 5.37 |
| 收盘价格 | 5.35 |
| 成交量 | 11,353,113 |
| 平均成交量 (3个月) | 5,608,585 |
| 市值 | 906,889,152 |
| 价格/销量 (P/S) | 0.390 |
| 股市价格/股市净资产 (P/B) | 0.720 |
| 52周波幅 |
| 营业毛利率 | -39.66% |
| 营业利益率 (TTM) | -8.73% |
| 稀释每股收益 (EPS TTM) | -5.91 |
| 季度收入增长率 (YOY) | -2.60% |
| 总债务/股东权益 (D/E MRQ) | 111.19% |
| 流动比率 (MRQ) | 1.68 |
| 营业现金流 (OCF TTM) | 300.68 M |
| 杠杆自由现金流 (LFCF TTM) | 243.04 M |
| 资产报酬率 (ROA TTM) | -3.01% |
| 股东权益报酬率 (ROE TTM) | -54.49% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 看跌 |
| Health Information Services (全球的) | 看跌 | 看跌 | |
| 股票 | Teladoc Health, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -0.5 |
| 内部交易活动 | -1.5 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.40 |
|
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Value |
| 内部持股比例 | 0.98% |
| 机构持股比例 | 74.10% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 11.00 (Deutsche Bank, 115.26%) | 购买 |
| 中 | 6.00 (17.42%) | |
| 低 | 5.00 (BMO Capital, -2.15%) | 保留 |
| 5.00 (Evercore ISI Group, -2.15%) | 保留 | |
| 平均值 | 6.96 (36.20%) | |
| 总计 | 4 购买, 7 保留 | |
| 平均价格@调整类型 | 5.32 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Deutsche Bank | 10 Mar 2026 | 11.00 (115.26%) | 购买 | 5.57 |
| Citigroup | 03 Mar 2026 | 6.00 (17.42%) | 保留 | 5.10 |
| 09 Jan 2026 | 9.00 (76.13%) | 保留 | 7.46 | |
| Oppenheimer | 03 Mar 2026 | 7.00 (36.99%) | 购买 | 5.10 |
| BMO Capital | 26 Feb 2026 | 5.00 (-2.15%) | 保留 | 5.35 |
| Canaccord Genuity | 26 Feb 2026 | 10.00 (95.69%) | 购买 | 5.35 |
| Evercore ISI Group | 26 Feb 2026 | 5.00 (-2.15%) | 保留 | 5.35 |
| Leerink Partners | 26 Feb 2026 | 5.50 (7.63%) | 保留 | 5.35 |
| Piper Sandler | 26 Feb 2026 | 9.00 (76.13%) | 购买 | 5.35 |
| Stifel | 26 Feb 2026 | 6.00 (17.42%) | 保留 | 5.35 |
| TD Cowen | 26 Feb 2026 | 6.00 (17.42%) | 保留 | 5.35 |
| Wells Fargo | 26 Feb 2026 | 6.00 (17.42%) | 保留 | 5.35 |
| 显示更多 | ||||
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| DIVITA CHARLES III | - | 5.47 | -27,731 | -151,689 |
| 累积净数量 | -27,731 | |||
| 累积净值 ($) | -151,689 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 5.47 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| DIVITA CHARLES III | 职员 | 11 Mar 2026 | 卖 (-) | 27,731 | 5.47 | 151,689 |
| DIVITA CHARLES III | 职员 | 10 Mar 2026 | 执行期权 | 64,653 | - | - |
| 日期 | 类型 | 细节 |
|---|---|---|
| 05 Mar 2026 | CNBC | Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S. |
| 05 Feb 2026 | 公告 | Teladoc Health to Announce Fourth Quarter 2025 Financial Results |
| 12 Jan 2026 | 公告 | Teladoc Health Launches Enhanced 24/7 Care Service |
| 05 Jan 2026 | 公告 | Teladoc Health to Participate in Upcoming Investor Conference |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合